Suppr超能文献

细胞治疗在输血科学和医学中的当前立场概述:从虚构的承诺到事实和观点,从红细胞替代到干细胞治疗。

An Overview of Current Position on Cell Therapy in Transfusion Science and Medicine: From Fictional Promises to Factual and Perspectives from Red Cell Substitution to Stem Cell Therapy.

机构信息

Romagna Transplant Network, Hematology Unit, Ravenna, Via Randi 5, Ravenna, Italy.

International Consultancy in Strategic Safety/Quality Innovations of Blood- Derived Bioproducts and Quality Audit/Inspection, London, England, UK.

出版信息

Transfus Apher Sci. 2020 Oct;59(5):102940. doi: 10.1016/j.transci.2020.102940. Epub 2020 Sep 4.

Abstract

Stem cell therapy is a relatively novel field of investigation, in which either differentiated cells or stem cells capable of differentiation are transplanted into an individual with the objective of yielding specific cell types in the damaged tissue and consequently restoring its function. The most successful example of cell therapy is hematopoietic stem cell transplantation, leading to regeneration of a patient's blood cells, now a widely established procedure for many oncologic and non-oncologic diseases. Innovative cell-based therapies are being developed to replace, regenerate or repair injured, absent, or diseased tissues and organs. However, cell therapy bioproducts are based on their inherent biological features such as proliferation, migratory, capability, plasticity, and capacity of self-renewal, posing serious challenges during such bioproduct development. The extraordinary promise of stem cells for future treatments of otherwise intractable diseases has raised great hope and expectations in patients, advocates, physicians, and researchers alike. However, despite thousands of scientific publications and research programs, increased efforts need to be put into the identification of the factors involved, biological mechanisms and materials that affect safety/ efficacy, and into the design of cost-effective methods for the harvesting, expansion, manipulation and purification of the cells.

摘要

干细胞疗法是一个相对较新的研究领域,通过将分化细胞或具有分化能力的干细胞移植到个体中,以产生损伤组织中的特定细胞类型,并由此恢复其功能。细胞疗法最成功的例子是造血干细胞移植,导致患者血细胞的再生,现在已成为许多肿瘤和非肿瘤疾病广泛应用的一种程序。创新性的基于细胞的疗法正在被开发,以替代、再生或修复受损、缺失或患病的组织和器官。然而,细胞治疗生物制品基于其内在的生物学特性,如增殖、迁移、能力、可塑性和自我更新能力,在生物制品开发过程中带来了严峻的挑战。干细胞在未来治疗其他难以治疗的疾病方面的巨大潜力,给患者、倡导者、医生和研究人员带来了巨大的希望和期望。然而,尽管有数千篇科学出版物和研究计划,仍需要投入更多的努力来确定涉及的因素、影响安全性/疗效的生物学机制和材料,并设计出具有成本效益的方法来收获、扩增、操作和纯化细胞。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验